Taxotere and Hair loss - a phase IV clinical study of FDA data
Summary:
We study 61,783 people who have side effects when taking Taxotere. Hair loss is found, especially among people who are female, 50-59 old, have been taking the drug for < 1 month, also take Neosar and have Breast cancer female.
The phase IV clinical study analyzes which people take Taxotere and have Hair loss. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
61,783 people reported to have side effects when taking Taxotere.
Among them, 34,336 people (55.58%) have Hair loss.
What is Taxotere?
Taxotere has active ingredients of docetaxel. It is used in breast cancer. Currently, eHealthMe is studying from 61,976 Taxotere users.
What is Hair loss?
Hair loss is found to be associated with 3,544 drugs and 3,391 conditions by eHealthMe. Currently, we are studying 258,060 people who have Hair loss.
Number of Taxotere and Hair loss reports submitted per year:
Time on Taxotere when people have Hair loss *:
Gender of people who have Hair loss when taking Taxotere*:
Age of people who have Hair loss when taking Taxotere *:
Common drugs people take besides Taxotere *:
Common side effects people have besides Hair loss *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Taxotere and have Hair loss?
Check whether Hair loss is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
- Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
Related studies
Taxotere side effects by duration, gender and age:
- Taxotere side effects (61,976 reports)
Hair loss treatments and more:
- Hair loss (258,060 reports)
Common drugs associated with Hair loss:
- Taxotere: 34,336 reports
- Docetaxel: 25,062 reports
- Methotrexate: 19,713 reports
- Humira: 17,448 reports
- Prednisone: 16,883 reports
- Enbrel: 14,300 reports
- Remicade: 12,381 reports
- Neosar: 12,108 reports
- Orencia: 11,906 reports
- Actemra: 10,367 reports
All the drugs that are associated with Hair loss:
- Hair loss (3,544 drugs)
Common conditions associated with Hair loss:
- Rheumatoid arthritis: 21,741 reports
- Multiple sclerosis: 14,215 reports
- Breast cancer: 11,443 reports
- Chemotherapy: 8,910 reports
- High blood pressure: 5,484 reports
All the conditions that are associated with Hair loss:
- Hair loss (3,391 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on docetaxel (the active ingredients of Taxotere) and Taxotere (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Etomidate and Temazepam drug interaction - 4 seconds ago
- Repatha and Irritable Bowel Syndrome - 13 seconds ago
- Aduhelm and Memantine Hydrochloride drug interaction - 28 seconds ago
- Nadolol and Viibryd drug interaction - 30 seconds ago
- Stalevo 100 and Muscle Function Loss - 37 seconds ago
- Kerydin and Revlimid drug interaction - 38 seconds ago
- Accutane and Reyataz drug interaction - 39 seconds ago
- Valtrex and Bactrim drug interaction - 45 seconds ago
- Ativan and Efavirenz drug interaction - 50 seconds ago
- Anafranil and Remodulin drug interaction - a minute ago